Affiliation
The Christie NHS Foundation Trust The Institute of Cancer Sciences, University of Manchester, Manchester Academic Health Sciences' Centre, Manchester, UKIssue Date
2016-08-23
Metadata
Show full item recordAbstract
Radiotherapy has the potential to augment the host's immune response to cancer. Urological malignancies are highly immunogenic and the combination of radiotherapy and immunotherapy shows promise. In this review, we discuss the effects of radiotherapy on the cancer immune system and highlight the rationale for using the combined approach in prostate, urothelial and renal cancers. Current clinical studies are summarized emphasising the synergistic effects of the combination and the possibility of improved clinical outcomes.Citation
Immunotherapy with radiotherapy in urological malignancies. 2016: Curr Opin UrolJournal
Current Opinion in UrologyDOI
10.1097/MOU.0000000000000335PubMed ID
27552139Type
ArticleLanguage
enISSN
1473-6586ae974a485f413a2113503eed53cd6c53
10.1097/MOU.0000000000000335
Scopus Count
Collections
Related articles
- [Combining radiotherapy with immunotherapy for urological malignancies].
- Authors: Rieken S, El Shafie R
- Issue date: 2018 Nov
- Combined Treatment of Radiotherapy and Immunotherapy for Urological Malignancies: Current Evidence and Clinical Considerations.
- Authors: Lei H, Shi M, Xu H, Bai S, Xiong X, Wei Q, Yang L
- Issue date: 2021
- A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response.
- Authors: Sundahl N, De Wolf K, Rottey S, Decaestecker K, De Maeseneer D, Meireson A, Goetghebeur E, Fonteyne V, Verbeke S, De Visschere P, Reynders D, Van Gele M, Brochez L, Ost P
- Issue date: 2017 Jun 29
- Cancer immunotherapy: A paradigm shift in the treatment of advanced urologic cancers.
- Authors: Gill DM, Agarwal N
- Issue date: 2017 Dec
- Combining Immunotherapy with Radiotherapy for the Treatment of Genitourinary Malignancies.
- Authors: Solanki AA, Bossi A, Efstathiou JA, Lock D, Mondini M, Ramapriyan R, Welsh J, Kang J
- Issue date: 2019 Feb